For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
In the latest session, Ensysce Biosciences Inc (NASDAQ: ENSC) closed at $1.77 up 4.12% from its previous closing price of $1.7. In other words, the price has increased by $4.12 from its previous closing price. On the day, 89984.0 shares were traded. ENSC stock price reached its highest trading level at $1.8 during the session, while it also had its lowest trading level at $1.68.
Ratios:
For a deeper understanding of Ensysce Biosciences Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.27 and its Current Ratio is at 1.27. In the meantime, Its Debt-to-Equity ratio is 0.30 whereas as Long-Term Debt/Eq ratio is at 0.00.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ENSC now has a Market Capitalization of 5254146 and an Enterprise Value of 4653868. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.40 while its Price-to-Book (P/B) ratio in mrq is 4.68. Its current Enterprise Value per Revenue stands at 1.037.
Stock Price History:
The Beta on a monthly basis for ENSC is 1.17, which has changed by -0.7705803 over the last 52 weeks, in comparison to a change of 0.12159383 over the same period for the S&P500. Over the past 52 weeks, ENSC has reached a high of $10.96, while it has fallen to a 52-week low of $1.52. The 50-Day Moving Average of the stock is -18.25%, while the 200-Day Moving Average is calculated to be -31.93%.
Shares Statistics:
For the past three months, ENSC has traded an average of 107.92K shares per day and 106480 over the past ten days. A total of 3.54M shares are outstanding, with a floating share count of 3.53M. Insiders hold about 0.35% of the company’s shares, while institutions hold 9.93% stake in the company. Shares short for ENSC as of 1763078400 were 82402 with a Short Ratio of 0.76, compared to 1760486400 on 163313. Therefore, it implies a Short% of Shares Outstanding of 82402 and a Short% of Float of 2.34.
Earnings Estimates
As of right now, 1.0 analysts gave their recommendation on the stock of the company. The consensus estimate for the next quarter is -$0.82, with high estimates of -$0.82 and low estimates of -$0.82.
Analysts are recommending an EPS of between -$4.32 and -$4.32 for the fiscal current year, implying an average EPS of -$4.32. EPS for the following year is -$2.23, with 1.0 analysts recommending between -$2.23 and -$2.23.
Revenue Estimates
A total of 1 analysts believe the company’s revenue will be $502.97k this quarter.It ranges from a high estimate of $502.97k to a low estimate of $502.97k. As of. The current estimate, Ensysce Biosciences Inc’s year-ago sales were $1.3M
A total of 1 analysts have provided revenue estimates for ENSC’s current fiscal year. The highest revenue estimate was $3.7M, while the lowest revenue estimate was $3.7M, resulting in an average revenue estimate of $3.7M. In the same quarter a year ago, actual revenue was $5.21M
